Three Abstracts Focusing on the Clinical Utility of Veracyte's Genomic Tests in ILD and Lung Cancer To Be Presented at ATS 2023 International Conference

Veracyte, Inc. today announced that three abstracts focused on the company’s genomic tests for interstitial lung disease and lung cancer will be presented at the American Thoracic Society ... | May 1, 2023

Related Keywords

University Of Washington ,Washington ,United States ,California ,South San Francisco ,American ,Ganesh Raghu ,Farah Madhani ,Diana Espinoza Barrera ,Tulane University ,American Thoracic Society ,Nasdaq ,International Conference ,Renown Health ,Waltere Washington Convention Center ,Twitter ,Veracyte Inc ,Envisia Genomic Classifier ,Percepta Nasal Swab ,Bill Bulman ,Genomic Classifier ,Usual Interstitial Pneumonia Predicts Progression ,Fibrotic Lung Disease Across ,Clinical Diagnoses ,Poster Discussion Session ,Convention Center ,Thematic Poster Session ,Lower Level ,Demonstrating Clinical Utility ,Nasal Genomic Classifier ,Lung Nodules ,Clinical Trial Learning Curve With ,Familiarization Phase ,Farah Madhani Lovely ,Street Level ,Annual Report ,Quarterly Report ,Veracyte ,Nc Stock Exchange ,News ,Information ,Press Release ,Oday ,Nnounced ,Hat ,Three ,Abstracts ,Ocused ,N ,The ,Enomic ,Tests ,Or ,Interstitial ,Young ,Disease ,End ,Dancer ,Hill ,He ,Resented ,It ,Thoracic ,Ociety Vcyt Us92337f1075 ,